{"id":17,"date":"2009-04-14T13:32:27","date_gmt":"2009-04-14T13:32:27","guid":{"rendered":"https:\/\/blogs.bmj.com\/case-reports\/?p=17"},"modified":"2009-04-14T13:32:27","modified_gmt":"2009-04-14T13:32:27","slug":"case-series-alzheimers-treatment-with-cphpc","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/","title":{"rendered":"Case series: Alzheimers treatment with CPHPC"},"content":{"rendered":"<p>A case series of 5 people with Alzheimers disease given CPHPC for 3 months which led to depletion of Serum Amyloid P component (SAP) in the blood and brain<sup>1<\/sup> is reported widely in the news.<\/p>\n<p><a href=\"http:\/\/www.sciencedaily.com\/releases\/2009\/04\/090413180706.htm\">http:\/\/www.sciencedaily.com\/releases\/2009\/04\/090413180706.htm<\/a><\/p>\n<p>It is good that CPHPC, a small molecule developed in conjunction with Roche and now owned by Pentraxin, is usually abbreviated as its long name is R-1-[6-[R-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl]pyrrolidine-2-carboxylic acid.<\/p>\n<p>Whilst an interesting observation of safety and efficacy this short case series is very early in the development of this interesting new compound and requires further research. The story however has been taken up by several news sources as a possible breakthrough in the treatment of Alzheimers.<\/p>\n<p>1) Simon E. Kolstoea SE, Basil H. Ridhab, Vittorio Bellottia, Nan Wangd, Carol V. Robinsond, Sebastian J. Crutchb, Geoffrey Keirc, Riitta Kukkastenvehmasb,, J. Ruth Gallimorea, Winston L. Hutchinsona, Philip N. Hawkinsa, Stephen P. Wooda, Martin N. Rossorb, Mark B. Pepysa. Molecular dissection of Alzheimer disease neuropathology by depletion of serum amyloid P component. PNAS, (in press)<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A case series of 5 people with Alzheimers disease given CPHPC for 3 months which led to depletion of Serum Amyloid P component (SAP) in the blood and brain1 is reported widely in the news. http:\/\/www.sciencedaily.com\/releases\/2009\/04\/090413180706.htm It is good that CPHPC, a small molecule developed in conjunction with Roche and now owned by Pentraxin, is [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":65,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[711],"tags":[],"class_list":["post-17","post","type-post","status-publish","format-standard","hentry","category-cases-in-the-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Case series: Alzheimers treatment with CPHPC - BMJ Case Reports blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Case series: Alzheimers treatment with CPHPC - BMJ Case Reports blog\" \/>\n<meta property=\"og:description\" content=\"A case series of 5 people with Alzheimers disease given CPHPC for 3 months which led to depletion of Serum Amyloid P component (SAP) in the blood and brain1 is reported widely in the news. http:\/\/www.sciencedaily.com\/releases\/2009\/04\/090413180706.htm It is good that CPHPC, a small molecule developed in conjunction with Roche and now owned by Pentraxin, is [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/\" \/>\n<meta property=\"og:site_name\" content=\"BMJ Case Reports blog\" \/>\n<meta property=\"article:published_time\" content=\"2009-04-14T13:32:27+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2009\\\/04\\\/14\\\/case-series-alzheimers-treatment-with-cphpc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2009\\\/04\\\/14\\\/case-series-alzheimers-treatment-with-cphpc\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Case series: Alzheimers treatment with CPHPC\",\"datePublished\":\"2009-04-14T13:32:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2009\\\/04\\\/14\\\/case-series-alzheimers-treatment-with-cphpc\\\/\"},\"wordCount\":184,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#organization\"},\"articleSection\":[\"Cases in the news\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2009\\\/04\\\/14\\\/case-series-alzheimers-treatment-with-cphpc\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2009\\\/04\\\/14\\\/case-series-alzheimers-treatment-with-cphpc\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2009\\\/04\\\/14\\\/case-series-alzheimers-treatment-with-cphpc\\\/\",\"name\":\"Case series: Alzheimers treatment with CPHPC - BMJ Case Reports blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#website\"},\"datePublished\":\"2009-04-14T13:32:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2009\\\/04\\\/14\\\/case-series-alzheimers-treatment-with-cphpc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2009\\\/04\\\/14\\\/case-series-alzheimers-treatment-with-cphpc\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2009\\\/04\\\/14\\\/case-series-alzheimers-treatment-with-cphpc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Case series: Alzheimers treatment with CPHPC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/\",\"name\":\"BMJ Case Reports blog\",\"description\":\"The official BMJ Case Reports blog, a place to discuss wider medical progress and implications.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#organization\",\"name\":\"BMJ Case Reports blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/files\\\/2017\\\/10\\\/blog-logo-case-reports.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/files\\\/2017\\\/10\\\/blog-logo-case-reports.png\",\"width\":224,\"height\":34,\"caption\":\"BMJ Case Reports blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/author\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Case series: Alzheimers treatment with CPHPC - BMJ Case Reports blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/","og_locale":"en_US","og_type":"article","og_title":"Case series: Alzheimers treatment with CPHPC - BMJ Case Reports blog","og_description":"A case series of 5 people with Alzheimers disease given CPHPC for 3 months which led to depletion of Serum Amyloid P component (SAP) in the blood and brain1 is reported widely in the news. http:\/\/www.sciencedaily.com\/releases\/2009\/04\/090413180706.htm It is good that CPHPC, a small molecule developed in conjunction with Roche and now owned by Pentraxin, is [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/","og_site_name":"BMJ Case Reports blog","article_published_time":"2009-04-14T13:32:27+00:00","twitter_card":"summary_large_image","twitter_misc":{"Written by":"","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/"},"author":{"name":"","@id":""},"headline":"Case series: Alzheimers treatment with CPHPC","datePublished":"2009-04-14T13:32:27+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/"},"wordCount":184,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#organization"},"articleSection":["Cases in the news"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/","url":"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/","name":"Case series: Alzheimers treatment with CPHPC - BMJ Case Reports blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#website"},"datePublished":"2009-04-14T13:32:27+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/case-reports\/2009\/04\/14\/case-series-alzheimers-treatment-with-cphpc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/case-reports\/"},{"@type":"ListItem","position":2,"name":"Case series: Alzheimers treatment with CPHPC"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/case-reports\/#website","url":"https:\/\/blogs.bmj.com\/case-reports\/","name":"BMJ Case Reports blog","description":"The official BMJ Case Reports blog, a place to discuss wider medical progress and implications.","publisher":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/case-reports\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/case-reports\/#organization","name":"BMJ Case Reports blog","url":"https:\/\/blogs.bmj.com\/case-reports\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/case-reports\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/case-reports\/files\/2017\/10\/blog-logo-case-reports.png","contentUrl":"https:\/\/blogs.bmj.com\/case-reports\/files\/2017\/10\/blog-logo-case-reports.png","width":224,"height":34,"caption":"BMJ Case Reports blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"","url":"https:\/\/blogs.bmj.com\/case-reports\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/posts\/17","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/users\/65"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/comments?post=17"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/posts\/17\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/media?parent=17"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/categories?post=17"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/tags?post=17"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}